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Abstract The von Willebrand Factor type A domain is the pro- 
totype for a protein superfamily. It possesses no significant se- 
quence similarity to any known protein structure. Secondary 
structure predictions indicate a largely alternating pattern of six 
c~-helices and six /3-strands. A protein fold for this domain is 
proposed to correspond to a doubly-wound open twisted 
/]-sheet structure flanked by a-helices. Close agreement was 
found with the GTP-binding domain of human ras-p21, provided 
that an extra ~-helix was inserted. The structure of the predicted 
fold showed high compatibility with the proximate location of two 
2+ • • Mg -binding Asp residues, two disulphide-bridged Cys residues, 
and other known functional attributes of this domain. 
2. Materials and methods 
The multiple sequence alignment for 75 vWF sequences was taken 
from [4]. Further alignments were generated by use of the multiple 
alignment program MULTAL with a range of fixed and variable gap 
penalties [15], and subsequently refined by eye. Alignments maximized 
the occurrence ofconserved orchemically similar esidues [4,5,16] and 
minimized the number of gaps. Protein coordinates were analysed for 
the location of their secondary structure lements using DSSP (Define 
Secondary Structure inProteins) [17]. Protein structures were visualised 
using INSIGHT II (Biosym Technologies plc) or SETOR software [18]. 
3. Results and discussion 
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1. Introduction 
The von Willebrand factor is a large glycoprotein found in 
blood plasma. Mutant forms are involved in the aetiology of 
bleeding disorders [1,2]. In von Willebrand factor, the type A 
domain (vWF) is the prototype for a protein superfamily con- 
taining at least 75 proteins that are similar in sequence [3,4]. 
This domain is found within other plasma proteins, at least four 
collagen types, several c~-subunits of integrins, and other ex- 
tracellular proteins. Fourier transform infrared spectroscopy 
on a recombinant vWF domain from human complement fac- 
tor B revealed 31% s-helix and 36%/J-sheet [4]. The calculation 
of an averaged secondary structure prediction from a sequence 
alignment offers improved statistical accuracies [5-7]. Such 
work lead to the assignment of the vWF fold to the et//J class 
of protein structures [4]. 
It is hypothesized that a protein crystal structure that 
matches this predicted secondary structure already exists in the 
Brookhaven Protein Data Bank. The prediction was compared 
against published topologies of known protein folds [8 10]. The 
vWF sequence compatibility with the structural features pres- 
ent in known three-dimensional structures was also assessed 
computationally using knowledge-based approaches [11-12]. 
We show that the GTP-binding fold of human ras-p21 [13,14] 
which contain a doubly wound open twisted/J-sheet flanked by 
c~-helices is readily identified as a good model for the vWF fold. 
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3.1. Averaged secondary structure predictions for 75 vWF 
sequences 
The previous prediction of the averaged secondary structure 
from 75 aligned vWF sequences utilised the unbiased GOR I 
and Chou-Fasman methods [19,20]. This revealed a largely 
alternating sequence of c~-helices (A) and fl-strands (B), which 
was identified to be B1, A2, B3, AB4, A5, AB6, B7, A8, B9, 
A10, Bl l  and A12 in that order [4] (AB means that either 
e-helix or/j-strand was present). AB4 and AB6 were oppositely 
assigned to c~-helix and fl-strand in the earlier predictions [4]. 
This resulted from closely similar probabilities for s-helix and 
/J-strand conformations. More recent algorithms PHD and SA- 
PIENS [6,7] were now employed in order to predict he consen- 
sus secondary structure directly from the sequence alignment 
and clarify the AB4 and AB6 predictions. Both assigned AB4 
and AB6 with greater confidence to be B4 and A6, respectively. 
As B4 was one of the shortest/J-strands, this may have influ- 
enced the difficulty in assignment. Six s-helices and six 
/J-strands were predicted for vWF in the order BAB- 
BAABABABA. The first three and final seven elements showed 
an alternation of c~-helices and/J-strands. 
3.2. Protein fold recognition from the v WF prediction 
Sequence database searches failed to reveal significant se- 
quence similarity at the > 30% level with sequences other than 
those within the vWF superfamily. Protein fold recognition 
procedures were thus used to assess the compatibility of the 
vWF sequence and prediction with known protein structures. 
An alternating pattern of u-helix and fl-strand as observed for 
B l-B3 and A6-A 12 is characteristic of a repeating fl-oL-fl motif 
[8]. Two fl-ct-fl motifs can be connected by an ~z-helix to form 
a parallel fl-sheet with four /j-strands in two ways. If the 
/j-strands are numbered sequentially, the 1 2 34  arrangement 
will produce a singly-wound closed/j-sheet barrel as in trio- 
sephosphate isomerase. As no closed barrel with fewer than 
eight fl-strands i known [10], this structure can be ruled out for 
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Fig. 1. Alignment of the human ras-p21 sequence with that for the vWF domain in human complement factor B to show the degree of correlation 
between the observed ras-p21 structure with that from the average of 75 GOR I predictions. Residue numberings from both ras-p21 and the consensus 
vWF sequence are shown. Similiar sequence and structure identities are denoted by vertical strokes. This gave 60 highly similar residue and 55 
structural identities. Dashes indicate sequence deletions in ras-p21 or <50% occupancy in the 75 vWF sequences. Dots, s and t in the DSSP output 
identifies loop regions in ras-p21. The GTP-binding residues in ras-p21 are asterisked. 
vWF. The 2 -1 -34  arrangement results in an open, twisted 
fl-sheet, which is doubly wound. The minimum number of 
fl-strands known for an open twisted fl-sheet with a-helices on 
both sides of the fl-sheet is four, and this is compatible with the 
vWF prediction. 
The April 1992 Brookhaven databank contains 208 protein 
folds, of which 38 are doubly-wound ~fl  folds [10]. Four groups 
of single domain ct/fl folds were identified [10], namely ras-p21 
and EF-Tu (5 c~-helices and 6 fl-strands in the order BAB- 
BABABABA), dihydrofolate r ductase (4 a and 8 fl; BABAB- 
BABABBB), adenylate kinase (10 ct and 5 fl; ABABAAABA- 
BAAABA) and phophoglycerate mutase (8 a and 5 fl; BAABA- 
BAAAABAB). The ras-p21 group came the closest o the 6 0c/6 
fl and BABBAABABABA predicted for vWF. Two protein 
fold recognition algorithms THREAD [11] and QSLAVE [12] 
were used to score sequence compatibility with a library of 
known protein folds. The vWF sequence of factor B was used 
as a search template. The ct/fl fold with the lowest pairwise and 
solvation pseudoenergy terms was identified by THREAD 
(Brookhaven codes and energy scores in brackets) to be ras-p21 
(5p21; -399 kcal/mol), which was followed by thioredoxin re- 
ductase (ltrb; -328 kcal/mol), guanylate kinase (lgky; -316 
kcal/mol), D-ribose binding protein (ldri; -300 kcal/mol), and 
others. QSLAVE gave similar scores for dihydrofolate reduc- 
tase, EF-Tu, adenylate kinase, ras-p21 and others. THREAD 
suggested a high similarity of the vWF sequence with the GTP- 
binding fold of human ras-p21. 
3.3. Comparison of the fold topology of ras-p21 with that 
predicted for vWF 
The alignment of the predicted vWF secondary structure 
against hat observed for ras-p21 is shown in Fig. 1. The sec- 
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(a) Observed ras-p21 
Kl17 A146 
147 
(b) Predicted vWF 
, - -1 • ,2 • e().o~ . , ,  
N:C6-C13 
[:)127 C135/ 
C:C195-C205 
Fig. 2. Supersecondary structure topologies for the open twisted r-sheet 
and (z-helices of ras-p21 and vWF. cz-Helices are represented as cylin- 
ders and r-strands are shown as arrows. Loops connect consecutive 
elements of secondary structure. Both topologies contain the same 
number of r-strands, but the vWF domain contains an extra s-helix A6 
which precedes r-strand B7 that forms part of the binding crevice with 
B1. (a) The secondary structure of ras-p21 shows the location (e) of 
residues on five loops at one side of the r-sheet hat constitutes the 
GTP-binding site of ras-p21, the N- and C-termini, and GI2 and A83 
that are replaced by Asp in vWF. (b) The predicted topology for the 
vWF domain shows the location (e) of the GP Ib receptor recognition 
peptide in human vWF between residues N16 to E44, as well as those 
of Asp 22 and Asp Iz7, the N- and C-terminal Cys residues, and the 
residues involved in the putative disulphide bridge between Cys 98- 
Cys135/Cys8 
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3.4. Validation of the predicted vWF foM by molecular graphics 
Almost all substrates or cofactor binding sites in a doubly 
wound ct/]] domain are located at a crevice lined by the loops 
that connect the central ]]-strands with the ~-helices [8,9]. In the 
proposed vWF fold, Fig. 2b shows that such a crevice is formed 
between B1 and B7, where the loops from the carboxy edge of 
two adjacent ]]-strands lead into opposite faces of the ]]-sheet 
(Fig. 3). Interestingly Asp 22 and Asp 127 which are highly con- 
served in many vWF sequences [4] have been implicated in the 
physiologically relevant role of Mg 2+ binding in the vWF of 
human CR3 [21]. These are located at the carboxy-ends of BI 
and B7 in the crevice. Despite their separation i the sequence, 
Fig. 3 predicts that they are adjacent in three-dimensional 
space. The three other groups of doubly-wound or~]] folds could 
not reproduce this proximity for reason of the connectivity of
the ~-helices and ]]-strands within their protein topologies. 
In vWF, 77% of Cys residues occur before residue 16 or after 
residue 194 [4]. CysS°9-Cys695 and Cys923Cysll°9 are disulphide 
bridges which enclose the A1 and A3 domains in human von 
Willebrand factor [22,23]. In the predicted vWF fold, the N- 
and C-termini are at the same side of the protein (Figs. 2 and 
3). Sequence comparisons shows that Cys6/Cys ~3 (vWF) pre- 
cedes ras-p21 by approximately 6 amino acids, and likewise 
Cys195/Cys2°4 (vWF) follows ras-p21. The distance between the 
c~-carbons of the N- and C-termini in ras-p21 is 1.9 nm (Fig. 
3). The predicted vWF topology is thus consistent with dis- 
ulphide bridge formation between Cys6/Cys 13 and CysJ95/Cys 2°4 
when these are present. 
ondary structure numbering follows [4,13]. MULTAL se- 
quence alignment for 12 vWF and 12 ras-p21 sequences taken 
from [4,14] showed that B1, A1, B2, B3 and A2 of ras-p21 could 
be correlated with B1, A2, B3, B4 and A5 of vWF. THREAD 
showed that B4, A3, B5, A4, B6 and A5 of ras-p21 could be 
aligned with B7, AS, B9, A10, Bl l  and A12 of vWF. The 
combination of both analyses uggested that A6 is the extra 
~-helix in vWF that is not present in ras-p21. A5 is not favoured 
as the extra a-helix as it exhibited greater sequence similarities 
with A2 in ras-p21 in Fig. 1. 
The topology of ras-p21 is compared with that proposed for 
vWF in Fig. 2. The vWF ]]-sheet is proposed to contain the 
same number of ]]-strands as ras-p21. A6 could be readily 
incorporated. The observed lengths of the ~-helices (10-17 res- 
idues) and ]]-strands (3-10 residues) in ras-p21 agree to within 
3 residues of the predicted lengths in vWF, with the exceptions 
of A2, B4 and A8 in vWF. The lengths of the connecting loops 
agreed to within 1-6 residues, except at the insertion point for 
A6 which is flanked by loops of 13 and 14 residues. These 
lengths are consistent with the proposed topology of Fig. 2. 
N-TermlnL Js  
Fig. 3. Ribbon diagram of human ras-p21 in terms of the proposed 
vWF fold. c~-Helices are represented as spiral ribbons, r-strands of the 
twisted r-sheet are shown as arrows, and loops are shown as ropes. The 
protein fold shows the open twisted r-sheet with six r-strands (B 11, B9, 
B7, B1, B4 and B3 from left to right) which is flanked by five s-helices 
(A12 and A2 in front of the r-sheet, and A8 and A5 behind it). The 
positions of the GP Ib-binding peptide, Asp22/Asp 127, the location of A6 
at Cys 98 (see text), and the N-and C-termini are labelled. 
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The remaining Cys residues are poorly conserved invWF [4]. 
The only pair which appear and disappear simultaneously at 
equivalent positions in the vWF alignment occurs in 4 se- 
quences at Cys 98 and Cys135/Cys 138 in human and chicken CoVI 
al-N1 and CoVI a2-N1. Interestingly, this involves the extra 
A6 helix, and is suggestive that A6 and A8 are disulphide linked 
(Fig. 2b). There are 34 residues between A5 and B7 in vWF 
(Fig. 1). This length is estimated tobe sufficient for the polypep- 
tide to extend towards A8 for disulphide bridge formation, then 
to pass back (Fig. 2b). Molecular graphics how that A6 can 
be inserted between A5 and A8 of vWF as required (Fig. 3). 
The carboxyl-edge of the parallel fl-sheet in ras-p21 (Fig. 2a) 
contains the GTP-binding site. Highly conserved residues in 
GTP-binding proteins include Phe 28, the NKxD motif at Lys ~7, 
and the SAK motif at Lys 147, all of which interact with guanine 
[13,14]. Two of these correspond to deletions in the vWF se- 
quence, while SAK becomes KVK (Fig. 1). Thr 35 and the 
GxxxxGK(S/T) and DxxG motifs, which are variously involved 
in Mg2+/phosphate interactions and switching between GDP 
and GTP binding, are also poorly conserved in the vWF se- 
quences [4]. These observations are consistent with the non- 
binding of GTP to vWF. Interestingly, the GxxxxGK(S/T) site 
for GTP in Fig. 2a is replaced by a vWF sequence in Fig. 2b 
that has been implicated in vWF recognition by the human 
platelet GP Ib-IX complex [1,2,24]. 
The molecular basis for mutant forms of human von Wil- 
lebrand factor in Type II von Willebrand Disease has been 
defined [1-3]. Type IIB disease is characterised by an increased 
affinity for GP Ib, and has been related to eight mutations 
involving residues M540, R543, R545, W550, V551, V553, P574 
and R578 in the A1 domain of human von Willebrand factor. 
The first six are located in the loop between A2 and B3 on the 
carboxyl-edge of the fl-sheet, while the last two relate to the end 
of the loop between B4 and A5 at the same edge. Fig. 2b shows 
that all eight residues occur in regions imilar to the GTP site 
in ras-p21. Type IIA disease involves a decreased affinity for 
GP Ib, and involves mutations at $743, R834, V844, $850, I865 
and E875. Those at $743, V844 and $850 are also located at the 
carboxy-edge of the fl-sheet in Fig. 2b, while the others are 
distributed between A6 and B7 (R834) and the centres of B9 
(I865) and A10 (E875). That involving R834 is particularly 
susceptible to proteolytic degradation [2], and is predicted to 
be on a surface-exposed loop in the vWF model which explains 
this susceptibility. While the situation with some of the Type 
IIA mutations i less clear-cut han that with Type IIB, the 
proposed vWF fold can be correlated with the increased affinity 
observed in Type IIB disease. 
4. Conclusions 
Of interest is that the structural similarity with ras-p21 has 
been identified for the vWF domain which is extracellular, even 
though ras-p21 is an intracellular p otein. This predicted model 
is able to account for the location of known functional groups, 
disulphide bridge connectivities and functional binding sites in 
vWF. The vWF model will be of value for functional and 
structural studies, although it should be noted that an atomic 
resolution structure determination will be required to verify it. 
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